Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

New and simple method for estimating metildigoxin dosing regimens by multiple trough screen analysis

E Yukawa1

  • 1Division of Pharmaceutical Sciences, Kyushu University, Fukuoka, Japan.

International Journal of Clinical Pharmacology and Therapeutics
|November 1, 1995
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Population pharmacokinetics of phenobarbital by mixed effect modelling using routine clinical pharmacokinetic data in Japanese neonates and infants: an update.

Journal of clinical pharmacy and therapeutics·2011
Same author

Effect of obesity on serum amiodarone concentration in Japanese patients: population pharmacokinetic investigation by multiple trough screen analysis.

Journal of clinical pharmacy and therapeutics·2009
Same author

Population pharmacokinetic investigation of low-dose methotrexate in rheumatoid arthritics Japanese patients.

Journal of clinical pharmacy and therapeutics·2007
Same author

Population pharmacokinetic investigation of digoxin in Japanese neonates.

Journal of clinical pharmacy and therapeutics·2007
Same author

Effect of CYP2C19 genetic polymorphism on pharmacokinetics of phenytoin and phenobarbital in Japanese epileptic patients using Non-linear Mixed Effects Model approach.

Journal of clinical pharmacy and therapeutics·2006
Same author

Population pharmacokinetics of theophylline in very premature Japanese infants with apnoea.

Journal of clinical pharmacy and therapeutics·2005

Patient characteristics like age and kidney function impact digitalis glycoside (metildigoxin) clearance. Understanding these factors improves dosing accuracy for therapeutic drug monitoring.

Area of Science:

  • Pharmacology
  • Clinical Pharmacy
  • Pharmacokinetics

Background:

  • Digitalis glycosides, like metildigoxin, require careful dosing to maintain therapeutic levels.
  • Patient-specific factors can significantly influence drug metabolism and elimination.
  • Accurate pharmacokinetic models are crucial for optimizing drug regimens.

Purpose of the Study:

  • To evaluate the influence of patient characteristics on metildigoxin pharmacokinetics.
  • To develop a population pharmacokinetic model for estimating metildigoxin dosing.
  • To assess the role of therapeutic drug monitoring data in refining dosage regimens.

Main Methods:

  • Analysis of 232 steady-state serum glycoside concentrations from 144 hospitalized patients.
  • Utilized NONMEM (NONlinear Mixed Effects Modeling) for population pharmacokinetic analysis.

Related Experiment Videos

  • Employed a simple steady-state pharmacokinetic model to describe digitalis glycoside behavior.

    • Main Results:

    • Metildigoxin clearance was significantly influenced by age, body weight, serum creatinine, gender, daily dose, and spironolactone coadministration.
    • Elderly patients exhibited lower clearance rates compared to younger individuals with similar weight and creatinine levels.
    • Interindividual variability in clearance was 19.7%, with residual variability at 21.8%.

    Conclusions:

    • Patient demographics and clinical factors are critical determinants of metildigoxin pharmacokinetics.
    • A NONMEM-based dosing method accurately predicts minimum steady-state concentrations.
    • This approach enhances the reliability of therapeutic drug monitoring for metildigoxin.